Reoperation for any reason postoperatively within 90 days after the date of surgery.
| Group | Value | 95% CI |
|---|---|---|
| Generic Implant | 0 | |
| Conventional Implant | 0 |
Last reviewed · How we verify
Do Generic Volar Locking Plates Provide Similar Outcomes at a Reduced Cost?
NA trial testing Generic Volar Locking Plate in Distal Radius Fractures in 101 participants. Completed in 30 April 2023.
| Lead sponsor | HealthPartners Institute |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 101 |
| Start date | 1 November 2022 |
| Primary completion | 30 April 2023 |
| Estimated completion | 30 April 2023 |
| Sites | 1 location across United States |
HealthPartners Institute
18 and older, any sex, with Distal Radius Fractures. Patients with the condition only — healthy volunteers not accepted.
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Reoperation for any reason postoperatively within 90 days after the date of surgery.
| Group | Value | 95% CI |
|---|---|---|
| Generic Implant | 0 | |
| Conventional Implant | 0 |
Readmission to the hospital for any reason postoperatively within 90 days after the date of surgery.
| Group | Value | 95% CI |
|---|---|---|
| Generic Implant | 0 | |
| Conventional Implant | 0 |
Patient death at any point within 90 days after the date of surgery.
| Group | Value | 95% CI |
|---|---|---|
| Generic Implant | 0 | |
| Conventional Implant | 0 |
The total cost of implants used in the procedure, including screws, pegs, volar locking plates, and disposable implants.
| Group | Value | 95% CI |
|---|---|---|
| Generic Implant | 702.38 | ± 47.83 |
| Conventional Implant | 1348.61 | ± 100.77 |
The total time in minutes from tourniquet inflation to deflation for a surgical case.
| Group | Value | 95% CI |
|---|---|---|
| Generic Implant | 49.05 | ± 19.2 |
| Conventional Implant | 45.06 | ± 12.84 |
Estimated blood loss for the surgical case as reported by the surgeon in milliliters.
| Group | Value | 95% CI |
|---|---|---|
| Generic Implant | 13.3 | ± 10.2 |
| Conventional Implant | 13.2 | ± 6.8 |
Across orthopedics, the investigators will be using the generic volar locking plates for patients undergoing open reduction and internal fixation (ORIF) of the distal radius using a block schedule, meaning one month we the generic implants and one month we use conventional implants from the surgeon's brand of choice. At the end of each month the health system will switch which type of implants (generic vs. conventional) they will use at their facilities. From a quality perspective each patient will be monitored both short and long term for complication and reoperation. This will be done through chart review.
1 peer-reviewed publication reference this trial (live from Europe PMC):
Verify or expand the search:
Currently open trials in the same condition.
Trials by the same sponsor.
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06343467.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing